Completed Clinical Trials

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

By April 24, 2017 No Comments


Malignant Mesothelioma

Estimated Enrollment: 61

Age Group: 18 Years to 120 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: CDR0000616162|S0722|U10CA032102

Study First Received: October 8, 2008

Last Updated: January 10, 2017

Estimated Primary Completion Date: April 2014


Primary Outcome Measures:

Progression-Free Survival|Response|Overall Survival|Frequency and Severity of Toxicities

Sponsors and Collaborators:

Southwest Oncology Group|National Cancer Institute (NCI)

Website Link:

Leave a Reply

Call Now ButtonCall Now